Neurokimika eta Neuroendekapena Ikerketa Taldea

• Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, Manuel I, Malek-Ahmadi M, Rodriguez-Puertas R, Mufson EJ.  Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. Journal of Alzheimer's Disease,  2024;  98(4),  1515 - 1532 -  1387-2877
• Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, Manuel I, Malek-Ahmadi M, Rodriguez-Puertas R, Mufson EJ.  Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. 2024
• Bengoetxea de Tena I, Moreno-Rodríguez M, Llorente-Ovejero A, Monge-Benito S, Martínez-Gardeazabal J, Onandia-Hinchado I, Manuel I, Giménez-Llort L, Rodríguez-Puertas R.  Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis Eur J Neurosci,  2022;  55(6),  1532 - 1546 -  0953-816X
• : Davis N, Mota BC, Stead L, Palmer EOC, Lombardero L, Rodríguez-Puertas R, de Paola V, Barnes SJ, Sastre M.  : Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. J Neuroinflammation, 18(1):73,  2021
• Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Lombardero L, González de San Román E, Manuel I, Giralt MT, Rodríguez-Puertas R.  Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. ACS Chemical Neuroscience (Q1),  2021;  2167 - 2181 -  1948-7193
• González de San Román E, Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Giménez-Llort L, Manuel I, Rodríguez-Puertas R.  Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease Int J Mol Sci (Q1),  2021;  22 (22),  1422-0067
• Rosell-Valle C, Pedraza C, Manuel I, Moreno-Rodríguez M, Rodríguez-Puertas R, Castilla-Ortega E, Caramés JM, Gómez Conde AI, Zambrana-Infantes E, Ortega-Pinazo J, Serrano-Castro PJ, Chun J, Rodríguez De Fonseca F, Santín LJ, Estivill-Torrús G.  Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry.,  2020;  Nov 2:110156
• Rodríguez-Puertas R.  ACE2 activators for the treatment of COVID 19 patients. J Med Virol.,  2020;  92(10):1701-1702.
• Papon MA, Le Feuvre Y, Barreda-Gómez G, Favereaux A, Farrugia F, Bouali-Benazzouz R, Nagy F, Rodríguez-Puertas R, Landry M.  Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats. Front Cell Neurosci.,  2020;  Jul 15;14:214.
• Rosell-Valle C, Pedraza C, Manuel I, Moreno-Rodríguez M, Rodríguez-Puertas R, Castilla-Ortega E, Caramés JM, Gómez Conde AI, Zambrana-Infantes E, Ortega-Pinazo J, Serrano-Castro PJ, Chun J, Rodríguez De Fonseca F, Santín LJ, Estivill-Torrús G.  Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry. (1),  2020;  Nov 2:110156.